- 米国企業
- SUTRO BIOPHARMA, INC.
SUTRO BIOPHARMA, INC.STRO
時価総額
$2.4億
PER
2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Revenue | 38 | 43 | 43 | 62 | 68 |
Research and development | 54 | 66 | 77 | 104 | 137 |
General and administrative | 21 | 33 | 37 | 56 | 60 |
Total operating expenses | 76 | 98 | 114 | 160 | 197 |
Loss from operations | -37 | -55 | -71 | -99 | -129 |
Interest income | 2 | 4 | 2 | 1 | 3 |
Unrealized gain (loss) on equity securities | - | - | 41 | -4 | 12 |
Interest and other income (expense), net | - | -4 | - | - | -3 |
Loss before provision for income taxes | - | - | - | - | -117 |
Provision for income taxes | - | - | - | - | 3 |
Net loss | -35 | -56 | -32 | -106 | -119 |
Net loss per share, basic | - | - | - | - | -2.35 |
Net loss per share, diluted | - | - | - | - | -2.35 |